
Help us create more content like this
Already a member? Sign in.
Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox.
President Donald Trump has issued a new executive order giving pharmaceutical companies a 30-day window to voluntarily lower prescription drug prices—or face federal intervention that could tie U.S. prices to those in other nations. Signed Monday, the directive charges Health Secretary Robert F. Kennedy Jr. with negotiating reduced rates within the month. If talks stall,…
Already a member? Sign in.
Already a member? Sign in.
Sign up to our newsletter to get the latest updates and events from the leading Afro-Diaspora publisher straight to your inbox, plus our curated weekly brief with top stories across our platforms.
No, Thank You